Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Milk, Human | 8 | 2024 | 490 | 2.290 |
Why?
|
Diabetes, Gestational | 4 | 2024 | 1263 | 1.330 |
Why?
|
Metformin | 4 | 2024 | 903 | 1.220 |
Why?
|
Diabetes Mellitus, Type 2 | 16 | 2024 | 12235 | 1.160 |
Why?
|
Metabolome | 5 | 2024 | 1005 | 1.090 |
Why?
|
Diabetes Mellitus, Type 1 | 13 | 2024 | 3445 | 1.010 |
Why?
|
Adiposity | 4 | 2024 | 1892 | 0.960 |
Why?
|
Body Composition | 5 | 2024 | 2441 | 0.890 |
Why?
|
Insulin Infusion Systems | 7 | 2022 | 221 | 0.870 |
Why?
|
Insulin Resistance | 4 | 2024 | 3988 | 0.810 |
Why?
|
Breast Feeding | 5 | 2024 | 1363 | 0.780 |
Why?
|
Hypoglycemic Agents | 12 | 2024 | 3107 | 0.770 |
Why?
|
Oleic Acids | 1 | 2021 | 70 | 0.710 |
Why?
|
Blood Glucose | 16 | 2024 | 6421 | 0.710 |
Why?
|
Prenatal Exposure Delayed Effects | 7 | 2019 | 2538 | 0.690 |
Why?
|
Paternal Exposure | 1 | 2019 | 100 | 0.640 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2020 | 85 | 0.630 |
Why?
|
Prediabetic State | 1 | 2022 | 547 | 0.530 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 1 | 2017 | 161 | 0.510 |
Why?
|
Malnutrition | 4 | 2017 | 629 | 0.510 |
Why?
|
Weight Gain | 4 | 2021 | 2356 | 0.500 |
Why?
|
Bile Acids and Salts | 1 | 2017 | 398 | 0.480 |
Why?
|
Adipose Tissue, Brown | 1 | 2021 | 776 | 0.470 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2020 | 855 | 0.470 |
Why?
|
Pregnancy | 24 | 2024 | 30233 | 0.470 |
Why?
|
Insulin | 12 | 2022 | 6604 | 0.410 |
Why?
|
Ventricular Remodeling | 1 | 2020 | 1276 | 0.400 |
Why?
|
Glucose Intolerance | 2 | 2013 | 578 | 0.380 |
Why?
|
Metabolic Diseases | 3 | 2017 | 686 | 0.380 |
Why?
|
DNA Methylation | 4 | 2019 | 4425 | 0.380 |
Why?
|
Birth Weight | 8 | 2022 | 2122 | 0.370 |
Why?
|
Pregnancy Complications | 5 | 2019 | 2970 | 0.360 |
Why?
|
Hyperinsulinism | 1 | 2013 | 402 | 0.350 |
Why?
|
Body Mass Index | 5 | 2021 | 13046 | 0.340 |
Why?
|
Pregnancy in Diabetics | 2 | 2024 | 198 | 0.330 |
Why?
|
Hypoglycemia | 3 | 2022 | 896 | 0.320 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2020 | 2136 | 0.320 |
Why?
|
Blood Glucose Self-Monitoring | 6 | 2022 | 475 | 0.320 |
Why?
|
Dyslipidemias | 2 | 2021 | 871 | 0.310 |
Why?
|
Glucose | 3 | 2022 | 4335 | 0.300 |
Why?
|
Fetal Blood | 1 | 2015 | 1365 | 0.300 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3930 | 0.280 |
Why?
|
Growth | 1 | 2009 | 365 | 0.270 |
Why?
|
Adolescent | 19 | 2024 | 88819 | 0.270 |
Why?
|
Obesity | 10 | 2022 | 13085 | 0.270 |
Why?
|
Mass Screening | 1 | 2022 | 5450 | 0.270 |
Why?
|
Stroke Volume | 1 | 2020 | 5595 | 0.260 |
Why?
|
Mice, Inbred ICR | 3 | 2017 | 361 | 0.240 |
Why?
|
Female | 41 | 2024 | 396233 | 0.240 |
Why?
|
Infant, Newborn | 7 | 2024 | 26381 | 0.230 |
Why?
|
Diabetes Complications | 1 | 2021 | 1318 | 0.230 |
Why?
|
Infant | 9 | 2024 | 36427 | 0.220 |
Why?
|
Kynurenine | 1 | 2024 | 142 | 0.220 |
Why?
|
Hyperglycemia | 3 | 2022 | 1389 | 0.220 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2024 | 126 | 0.210 |
Why?
|
Pancreas, Artificial | 2 | 2020 | 54 | 0.200 |
Why?
|
C-Peptide | 1 | 2024 | 443 | 0.190 |
Why?
|
Adipocytes | 1 | 2009 | 1196 | 0.190 |
Why?
|
Growth Hormone | 1 | 2024 | 567 | 0.190 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2012 | 3606 | 0.190 |
Why?
|
Spermatozoa | 2 | 2017 | 627 | 0.190 |
Why?
|
S-Adenosylmethionine | 1 | 2023 | 219 | 0.190 |
Why?
|
Child | 15 | 2024 | 80573 | 0.190 |
Why?
|
Humans | 45 | 2024 | 766117 | 0.180 |
Why?
|
Betaine | 1 | 2021 | 90 | 0.180 |
Why?
|
Male | 26 | 2024 | 363935 | 0.180 |
Why?
|
Cytomegalovirus | 1 | 2024 | 753 | 0.170 |
Why?
|
Adiponectin | 2 | 2024 | 1120 | 0.170 |
Why?
|
Treatment Failure | 2 | 2022 | 2653 | 0.160 |
Why?
|
Epigenesis, Genetic | 4 | 2022 | 3818 | 0.150 |
Why?
|
Factitious Disorders | 1 | 2018 | 39 | 0.150 |
Why?
|
Adult | 17 | 2024 | 223139 | 0.150 |
Why?
|
Cytomegalovirus Infections | 1 | 2024 | 837 | 0.140 |
Why?
|
Mothers | 3 | 2022 | 2206 | 0.140 |
Why?
|
Risk Factors | 9 | 2023 | 74857 | 0.140 |
Why?
|
Ursodeoxycholic Acid | 1 | 2017 | 81 | 0.140 |
Why?
|
Metabolomics | 2 | 2016 | 1667 | 0.130 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2024 | 1935 | 0.130 |
Why?
|
Fetal Development | 2 | 2018 | 777 | 0.120 |
Why?
|
Umbilical Cord | 1 | 2016 | 178 | 0.120 |
Why?
|
Fetal Nutrition Disorders | 1 | 2014 | 8 | 0.120 |
Why?
|
Follow-Up Studies | 4 | 2023 | 39243 | 0.120 |
Why?
|
Feeding Behavior | 2 | 2011 | 3209 | 0.120 |
Why?
|
Prospective Studies | 4 | 2024 | 54812 | 0.110 |
Why?
|
Maternal Nutritional Physiological Phenomena | 3 | 2016 | 395 | 0.110 |
Why?
|
Fathers | 1 | 2017 | 377 | 0.110 |
Why?
|
Biosensing Techniques | 1 | 2020 | 640 | 0.110 |
Why?
|
Epigenomics | 2 | 2017 | 959 | 0.110 |
Why?
|
Child Development | 1 | 2024 | 2327 | 0.100 |
Why?
|
Young Adult | 8 | 2024 | 59868 | 0.100 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2013 | 558 | 0.090 |
Why?
|
Regression Analysis | 1 | 2021 | 6324 | 0.090 |
Why?
|
Adolescent Behavior | 1 | 2020 | 1184 | 0.090 |
Why?
|
Endocrine Disruptors | 1 | 2014 | 264 | 0.090 |
Why?
|
Nutritional Status | 2 | 2017 | 1620 | 0.090 |
Why?
|
Animals | 14 | 2022 | 168800 | 0.090 |
Why?
|
Gestational Age | 1 | 2019 | 3616 | 0.090 |
Why?
|
Genomic Imprinting | 1 | 2012 | 326 | 0.090 |
Why?
|
Mice | 11 | 2022 | 81839 | 0.090 |
Why?
|
Disease Susceptibility | 1 | 2017 | 1790 | 0.080 |
Why?
|
Case-Control Studies | 2 | 2020 | 22228 | 0.080 |
Why?
|
Midline Thalamic Nuclei | 1 | 2009 | 14 | 0.080 |
Why?
|
Phthalic Acids | 1 | 2014 | 485 | 0.080 |
Why?
|
CpG Islands | 1 | 2013 | 1207 | 0.080 |
Why?
|
Hyperphagia | 1 | 2009 | 139 | 0.080 |
Why?
|
Health Behavior | 1 | 2020 | 2649 | 0.070 |
Why?
|
Cohort Studies | 4 | 2024 | 41684 | 0.070 |
Why?
|
Pregnancy Outcome | 1 | 2019 | 2969 | 0.070 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1893 | 0.070 |
Why?
|
Massachusetts | 1 | 2021 | 8882 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2024 | 12803 | 0.070 |
Why?
|
Risk | 2 | 2017 | 9599 | 0.070 |
Why?
|
Echocardiography | 1 | 2020 | 5041 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2022 | 5791 | 0.070 |
Why?
|
Haplotypes | 1 | 2013 | 2726 | 0.070 |
Why?
|
Cell Size | 1 | 2009 | 626 | 0.070 |
Why?
|
Histones | 1 | 2017 | 2591 | 0.070 |
Why?
|
Preventive Medicine | 1 | 2008 | 246 | 0.070 |
Why?
|
MicroRNAs | 1 | 2022 | 3787 | 0.060 |
Why?
|
Satiety Response | 1 | 2005 | 47 | 0.060 |
Why?
|
Taxes | 1 | 2008 | 219 | 0.060 |
Why?
|
Cities | 1 | 2008 | 542 | 0.060 |
Why?
|
Environmental Pollutants | 1 | 2014 | 1294 | 0.060 |
Why?
|
School Health Services | 1 | 2008 | 388 | 0.060 |
Why?
|
Dietary Supplements | 1 | 2017 | 3427 | 0.060 |
Why?
|
Nutrition Policy | 1 | 2008 | 467 | 0.060 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15647 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14747 | 0.050 |
Why?
|
Health Status | 1 | 2017 | 4086 | 0.050 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2024 | 120 | 0.050 |
Why?
|
Age Factors | 1 | 2020 | 18386 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10380 | 0.050 |
Why?
|
Disease Progression | 1 | 2020 | 13616 | 0.050 |
Why?
|
S-Adenosylhomocysteine | 1 | 2023 | 39 | 0.050 |
Why?
|
Body Weight | 1 | 2013 | 4626 | 0.050 |
Why?
|
Tryptophan | 1 | 2024 | 483 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 3108 | 0.050 |
Why?
|
Proinsulin | 1 | 2022 | 135 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 26290 | 0.050 |
Why?
|
Disclosure | 1 | 2008 | 756 | 0.050 |
Why?
|
Biology | 1 | 2024 | 293 | 0.050 |
Why?
|
Diet | 1 | 2019 | 8087 | 0.050 |
Why?
|
Child, Preschool | 2 | 2022 | 42511 | 0.040 |
Why?
|
Sample Size | 1 | 2023 | 843 | 0.040 |
Why?
|
Methionine | 1 | 2023 | 569 | 0.040 |
Why?
|
Prognosis | 1 | 2021 | 29912 | 0.040 |
Why?
|
Time Factors | 2 | 2020 | 40108 | 0.040 |
Why?
|
Fructose | 1 | 2022 | 285 | 0.040 |
Why?
|
Wound Healing | 1 | 2011 | 2795 | 0.040 |
Why?
|
Homocysteine | 1 | 2023 | 638 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2016 | 11906 | 0.040 |
Why?
|
Carbon | 1 | 2023 | 673 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2023 | 992 | 0.040 |
Why?
|
Lactation | 1 | 2021 | 391 | 0.040 |
Why?
|
Brain | 1 | 2005 | 27177 | 0.040 |
Why?
|
Germany | 1 | 2021 | 882 | 0.040 |
Why?
|
Israel | 1 | 2021 | 729 | 0.040 |
Why?
|
Stem Cells | 1 | 2011 | 3537 | 0.040 |
Why?
|
Glucosides | 1 | 2022 | 532 | 0.030 |
Why?
|
Adipose Tissue | 1 | 2009 | 3315 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2023 | 1194 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2022 | 871 | 0.030 |
Why?
|
Disease Outbreaks | 1 | 2005 | 1761 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2011 | 4959 | 0.030 |
Why?
|
Nutritional Support | 1 | 2017 | 178 | 0.030 |
Why?
|
Benzhydryl Compounds | 1 | 2022 | 943 | 0.030 |
Why?
|
Age of Onset | 1 | 2022 | 3344 | 0.030 |
Why?
|
Viral Load | 1 | 2024 | 3386 | 0.030 |
Why?
|
Aging | 1 | 2013 | 8723 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2005 | 2894 | 0.030 |
Why?
|
Animals, Newborn | 2 | 2011 | 2677 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2023 | 2689 | 0.030 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 1121 | 0.030 |
Why?
|
Absorptiometry, Photon | 2 | 2011 | 1707 | 0.030 |
Why?
|
Mexican Americans | 1 | 2014 | 165 | 0.030 |
Why?
|
United States | 4 | 2023 | 72920 | 0.020 |
Why?
|
Caloric Restriction | 1 | 2014 | 303 | 0.020 |
Why?
|
Placentation | 1 | 2012 | 78 | 0.020 |
Why?
|
Equipment Design | 1 | 2019 | 3489 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2014 | 947 | 0.020 |
Why?
|
Hypertension | 1 | 2021 | 8616 | 0.020 |
Why?
|
Lipids | 1 | 2022 | 3316 | 0.020 |
Why?
|
Nucleosomes | 1 | 2014 | 492 | 0.020 |
Why?
|
Heart | 1 | 2023 | 4419 | 0.020 |
Why?
|
Environment | 1 | 2016 | 1119 | 0.020 |
Why?
|
Testis | 1 | 2013 | 782 | 0.020 |
Why?
|
Prenatal Care | 1 | 2017 | 1158 | 0.020 |
Why?
|
Muscle Development | 1 | 2011 | 258 | 0.020 |
Why?
|
Models, Statistical | 1 | 2023 | 5089 | 0.020 |
Why?
|
Genome | 1 | 2016 | 1753 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 12426 | 0.020 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2011 | 552 | 0.020 |
Why?
|
Environmental Monitoring | 1 | 2014 | 1467 | 0.020 |
Why?
|
Embryonic Development | 1 | 2012 | 719 | 0.020 |
Why?
|
Cell Count | 1 | 2011 | 1825 | 0.020 |
Why?
|
Triglycerides | 1 | 2014 | 2441 | 0.020 |
Why?
|
Maternal-Fetal Exchange | 1 | 2008 | 453 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2014 | 1735 | 0.020 |
Why?
|
Leptin | 1 | 2014 | 1596 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2007 | 610 | 0.020 |
Why?
|
Organ Size | 1 | 2011 | 2260 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16716 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2014 | 3227 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2023 | 16040 | 0.010 |
Why?
|
Dietary Fats | 1 | 2011 | 2003 | 0.010 |
Why?
|
Mitochondria | 1 | 2016 | 3672 | 0.010 |
Why?
|
Fetal Growth Retardation | 1 | 2007 | 591 | 0.010 |
Why?
|
Placenta | 1 | 2012 | 1726 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12976 | 0.010 |
Why?
|
Mice, Inbred NOD | 1 | 2007 | 1837 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2014 | 3853 | 0.010 |
Why?
|
Transcription Factors | 1 | 2022 | 12130 | 0.010 |
Why?
|
Regeneration | 1 | 2011 | 1516 | 0.010 |
Why?
|
Aged | 3 | 2020 | 171219 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9527 | 0.010 |
Why?
|
Sex Factors | 1 | 2014 | 10614 | 0.010 |
Why?
|
Middle Aged | 3 | 2020 | 223083 | 0.010 |
Why?
|
Inflammation | 1 | 2016 | 10860 | 0.010 |
Why?
|
Liver | 1 | 2012 | 7559 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2022 | 65219 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 22341 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2018 | 81565 | 0.010 |
Why?
|
Incidence | 1 | 2007 | 21513 | 0.000 |
Why?
|
Concepts
(223)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.